Sp905

PANEL DISCUSSION

Date
May 8, 2023
Explore related products in the following collection:

Society: AGA

Management of diseases of the ileo-anal pouch and perianal Crohn’s disease is challenging and involves multidisciplinary medical and surgical care. This session review the contemporary management of these complex clinical situations. It will also update the clinician and researcher on the emerging concepts of fibrosis as a therapeutic target as well as aging and frailty in in the management of IBD.

Presenters

Speaker Image for Peter Higgins
University of Michigan
Speaker Image for Stefan Holubar
Cleveland Clinic
Speaker Image for Maia Kayal
Icahn School of Medicine Mount Sinai Hospital
Speaker Image for Bharati Kochar
Massachusetts General Hospital

Tracks

Related Products

Thumbnail for REDUCED ACCESS TO BIOLOGIC MEDICATIONS IN SOCIALLY VULNERABLE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
REDUCED ACCESS TO BIOLOGIC MEDICATIONS IN SOCIALLY VULNERABLE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
BACKGROUND: The impact of pregnancy on vedolizumab (VDZ) and ustekinumab (UST) pharmacokinetics is not well defined. Similarly, the time to infant clearance and outcomes following in-utero exposure require elucidation…
Thumbnail for THE NEXT THERAPEUTIC FRONTIER IN IBD — WHERE ARE WE WITH TARGETING FIBROSIS?
THE NEXT THERAPEUTIC FRONTIER IN IBD — WHERE ARE WE WITH TARGETING FIBROSIS?
Management of diseases of the ileo-anal pouch and perianal Crohn’s disease is challenging and involves multidisciplinary medical and surgical care. This session review the contemporary management of these complex clinical situations…
Thumbnail for TREATING IBD IN OLDER ADULTS: HOW TO BALANCE SAFETY, EFFICACY, AND FRAILTY
TREATING IBD IN OLDER ADULTS: HOW TO BALANCE SAFETY, EFFICACY, AND FRAILTY
Management of diseases of the ileo-anal pouch and perianal Crohn’s disease is challenging and involves multidisciplinary medical and surgical care. This session review the contemporary management of these complex clinical situations…
Thumbnail for CHANGES IN THERAPY ARE NOT ASSOCIATED WITH INCREASED REMISSION IN PATIENTS WITH CROHN’S DISEASE OF THE POUCH
CHANGES IN THERAPY ARE NOT ASSOCIATED WITH INCREASED REMISSION IN PATIENTS WITH CROHN’S DISEASE OF THE POUCH
BACKGROUND: Prevention of postoperative recurrence (POR) in Crohn’s disease (CD) after ileo-colonic (IC) resection is still a highly debated topic. Prophylactic immunosuppression after surgery is currently recommended in presence of at least one clinical risk factor (RF)…